European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts)

Gender Differences in the Prevalence and Determinants of the Metabolic Syndrome in Screened Subjects at Risk for Coronary Heart Disease

Tonstad, S., Sandvik, E., Larsen, P. G. L., & Thelle, D. S. (2007) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2006.0037 · Cited by 24

Can we really predict risk of cancer?

Thrift, A. P., & Whiteman, D. C. (2013) · Cancer Epidemiology · doi:10.1016/j.canep.2013.04.002 · Cited by 22

Developmental Mechanisms Involved in the Primary Prevention of Atherosclerosis and Cardiovascular Disease

Claudio Napoli, A. (2011) · Current Atherosclerosis Reports · doi:10.1007/s11883-010-0156-x · Cited by 24

Link between traditional cardiovascular risk factors and inflammation in patients with early arthritis: Results from a French Multicenter Cohort

Boyer, J., Bongard, V., Cantagrel, A. G., Jamard, B., Gottenberg, J., Mariette, X., Davignon, J., Ferrières, J., Ruidavets, J., Dallongeville, J., et al. (2012) · Arthritis Care & Research · doi:10.1002/acr.21623 · Cited by 26

Synergistic Effects between Q192R Polymorphism of Paraoxonase 1 Gene and Some Conventional Risk Factors in Premature Coronary Artery Disease

Balcerzyk, A., Żak, I., & Krauze, J. (2007) · Archives of Medical Research · doi:10.1016/j.arcmed.2007.03.004 · Cited by 24

Leukocyte count is associated with incidence of coronary events, but not with stroke: A prospective cohort study

Li, C., Engström, G., & Hedblad, B. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.09.029 · Cited by 24

Efficacy of n-3 polyunsaturated fatty acids and feasibility of optimizing preventive strategies in patients at high cardiovascular risk: rationale, design and baseline characteristics of the Rischio and Prevenzione study, a large randomised trial in general practice

Rischio and Prevenzione Investigators (2010) · Trials · doi:10.1186/1745-6215-11-68 · Cited by 24

Effect of a cardiovascular prevention program on health behavior and BMI in highly educated adults: A randomized controlled trial

Jacobs, N., Bourdeaudhuij, I. D., Thijs, H., Dendale, P., & Claes, N. (2010) · Patient Education and Counseling · doi:10.1016/j.pec.2010.08.024 · Cited by 25

Mortality and cardiovascular morbidity among long‐term endurance male cross country skiers followed for 28–30 years

Grimsmo, J., Mæhlum, S., Moelstad, P., & Arnesen, H. (2011) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/j.1600-0838.2011.01307.x · Cited by 24

Determinants of coronary flow velocity reserve in healthy young men

Kiviniemi, T., Snapir, A., Saraste, M., Toikka, J., Raitakari, O. T., Ahotupa, M. O., Hartiala, J., Scheinin, M., & Koskenvuo, J. W. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00915.2005 · Cited by 24

Combustion Particle-Induced Changes in Calcium Homeostasis: A Contributing Factor to Vascular Disease?

Holme, J. A., Brinchmann, B. C., Ferrec, E. L., Lagadic‐Gossmann, D., & Øvrevik, J. (2019) · Cardiovascular Toxicology · doi:10.1007/s12012-019-09518-9 · Cited by 23

The evolution of European guidelines: Changing the management of cholesterol levels

Erhardt, L., & Gotto, A. M. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.10.001 · Cited by 23

Review article: hyperlipidaemia and cardiovascular risk

Bertolotti, M., Maurantonio, M., Gabbi, C., et al. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02591.x · Cited by 24

Efecto de una intervención global sobre el control integral de múltiples factores de riesgo en pacientes con alto o muy alto riesgo cardiovascular. Estudio CIFARC 2

Fernández, A. D. L. P., Roca, B., Cuende, J. I., Alborch, J. R. C., Santiago, J. M., Rodríguez, M. M., Selfa, M. P., & Fernández, C. S. (2007) · Revista Clínica Española · doi:10.1157/13100222 · Cited by 24

Cost effectiveness of rimonabant use in patients at increased cardiometabolic risk: estimates from a Markov model

Jaime, J., Stillman, I. Ö., Danel, A., Getsios, D., & McEwan, P. (2007) · Journal of Medical Economics · doi:10.3111/13696990701438629 · Cited by 24

Trends in Cardiovascular Disease Risk Factor Prevalence and Estimated 10-Year Cardiovascular Risk Scores in a Large Untreated French Urban Population: The CARVAR 92 Study

Karam, C., Beauchet, A., Czernichow, S., de Roquefeuil, F., Alain, B., Mansencal, N., & Dubourg, O. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124817 · Cited by 24

The PreCardio-study protocol – a randomized clinical trial of a multidisciplinary electronic cardiovascular prevention programme

Claes, N., & Jacobs, N. (2007) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-7-27 · Cited by 26

Niaspan®: creating a new concept for raising HDL-cholesterol

McGovern, M. (2005) · European Heart Journal Supplements · doi:10.1093/eurheartj/sui042 · Cited by 24

Guidelines on cardiovascular disease prevention in clinical practice: the European perspective

Graham, I. M. (2005) · Current Opinion in Cardiology · doi:10.1097/01.hco.0000176405.56119.54 · Cited by 24

Is there a need for novel cardiovascular risk factors?

von Eckardstein, A. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh111 · Cited by 24

Erectile dysfunction as a risk factor for coronary heart disease: implications for prevention

Tikkanen, M. J., Jackson, G., Tammela, T. L. J., Assmann, G., Palomäki, A., Kupari, M. M., & OLSSON, A. G. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2006.01271.x · Cited by 24

The 2003 Canadian recommendations for dyslipidemia management: Revisions are needed

Manuel, D. G. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.1040202 · Cited by 24

Blood biomarkers of progressive atherosclerosis and restenosis after stenting of symptomatic intracranial artery stenosis

Haidegger, M., Kneihsl, M., Niederkorn, K., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-95135-y · Cited by 23

The Global Risk Approach Should Be Better Applied in French Hypertensive Patients: A Comparison between Simulation and Observation Studies

Marchant, I., Nony, P., Cucherat, M., Boissel, J., Thomas, S., Bejan‐Angoulvant, T., Laugerotte, A., Kahoul, R., & Gueyffier, F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017508 · Cited by 23

The prevalence of concomitant hypertension and hypercholesterolaemia in the general population

Bacquer, D. D., & Backer, G. D. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.08.037 · Cited by 23

Comprehensive cardiovascular risk management – what does it mean in practice?-0

Erhardt, L., Moller, R. A., & Puig, J. G. (2011) · PubMed Central · doi:10.6084/m9.figshare.77223 · Cited by 23

Statin use and cardiovascular risk factors in diabetic patients developing a first myocardial infarction

Mortensen, M. B., Kulenovic, I., & Falk, E. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0400-y · Cited by 23

Extensive carotid atherosclerosis and the diagnostic accuracy of coronary risk calculators

Romanens, M., Mortensen, M. B., Sudano, I., Szucs, T. D., & Adams, A. (2017) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2017.03.006 · Cited by 23

Substantial improvement of primary cardiovascular prevention by a systematic score-based multimodal approach: A randomized trial: The PreFord-Study

Gysan, D. B., Millentrup, S., Albus, C., Bjarnason‐Wehrens, B., Latsch, J., Gohlke, H., Herold, G., Wegscheider, K., Heming, C., Seyfarth, M., et al. (2017) · European Journal of Preventive Cardiology · doi:10.1177/2047487317718081 · Cited by 23

Lipid disorders in hospital attendants in Kumasi, Ghana.

Micah, F. B., & Nkum, B. C. (2012) · Europe PMC (PubMed Central) · Cited by 24

Prolonged-release nicotinic acid for the management of dyslipidemia: an update including results from the NAUTILUS study

Vogt, A. (2007) · Vascular Health and Risk Management · doi:10.2147/vhrm.s1023 · Cited by 23

Risk Charts Illustrating the 10-year Risk of Stroke among Residents of Japanese Rural Communities: The JMS Cohort Study

Ishikawa, S., Matsumoto, M., Kayaba, K., Gotoh, T., Nago, N., Tsutsumi, A., & Kajii, E. (2009) · Journal of Epidemiology · doi:10.2188/jea.je20080092 · Cited by 23

Rosuvastatin is cost-effective compared with atorvastatin in reaching cholesterol goals

Hirsch, M., O’Donnell, J. C., & OLSSON, A. G. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2004.09.015 · Cited by 23

Go red for women

Kornacewicz-Jach, Z., Kossuth, I., & Czechowska, M. (2006) · Menopause Review/Przegląd Menopauzalny · Cited by 24

Arterial stiffness in diabetes and hypertension

Lim, H. S., & Lip, G. Y. H. (2004) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001693 · Cited by 23

Maximizing coronary disease risk reduction using nicotinic acid combined with LDL-lowering therapy

Brown, B. G. (2005) · European Heart Journal Supplements · doi:10.1093/eurheartj/sui041 · Cited by 23

The metabolic syndrome

Unwin, N. C. (2006) · Journal of the Royal Society of Medicine · doi:10.1258/jrsm.99.9.457 · Cited by 30

The realities of dyslipidaemia: what do the studies tell us?

Kastelein, J. J. P. (2005) · European Heart Journal Supplements · doi:10.1093/eurheartj/sui040 · Cited by 23

Original research Risk factor control and adherence to treatment in patients with coronary heart disease in the Republic of Srpska, Bosnia and Herzegovina in 2005-2006

Vulić, D., Loncar, S., Krneta, M., Škrbić, R., Lazarevic, A., Lee, B. T., López, V. A., & Wong, N. D. (2010) · Archives of Medical Science · doi:10.5114/aoms.2010.13891 · Cited by 22

Quality of Life Changes in Acute Coronary Syndromes Patients: A Systematic Review and Meta-Analysis

Kaambwa, B., Gesesew, H., Horsfall, M., & Chew, D. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17186889 · Cited by 20

Priority setting in health care: on the relation between reasonable choices on the micro-level and the macro-level

Bærøe, K. (2008) · Metamedicine · doi:10.1007/s11017-008-9063-3 · Cited by 23

The relationship between early left ventricular myocardial alterations and reduced coronary flow reserve in non-insulin-dependent diabetic patients with microvascular angina

D’Andrea, A., Nistri, S., Castaldo, F., et al. (2010) · International Journal of Cardiology · doi:10.1016/j.ijcard.2010.09.044 · Cited by 22

Patient expectations on lipid-lowering drugs.

Lytsy, P., & Westerling, R. (2007) · Patient Education and Counseling · doi:10.1016/j.pec.2007.03.004 · Cited by 23

Individualized Angiotensin‐Converting Enzyme (ACE)‐Inhibitor Therapy in Stable Coronary Artery Disease Based on Clinical and Pharmacogenetic Determinants: The PERindopril GENEtic (PERGENE) Risk Model

Oemrawsingh, R. M., Akkerhuis, K. M., van Vark, L. C., Redekop, K., Rudež, G., Remme, W. J., Bertrand, M. E., Fox, K. M., Ferrari, R., Danser, A. H. J., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002688 · Cited by 22

Relapsing polychondritis: prevalence of cardiovascular diseases and its risk factors, and general disease features according to gender

Pallo, P. A. O., Levy‐Neto, M., Pereira, R. M. R., & Shinjo, S. K. (2017) · Revista Brasileira de Reumatologia (English Edition) · doi:10.1016/j.rbre.2017.02.003 · Cited by 21

The effect of genotype and drying condition on the bioactive compounds of sour cherry pomace

Ciccoritti, R., Paliotta, M., Centioni, L., et al. (2017) · European Food Research and Technology · doi:10.1007/s00217-017-2982-3 · Cited by 22

Canakinumab for secondary prevention of atherosclerotic disease

Capodanno, D., & Angiolillo, D. J. (2017) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2018.1420776 · Cited by 22

The ‘COmorBidity in Relation to AIDS’ (COBRA) cohort: Design, methods and participant characteristics

Francesco, D. D., Wit, F. W. N. M., Cole, J. H., Kootstra, N. A., Winston, A., Sabin, C. A., Underwood, J., van Zoest, R. A., Schouten, J., Kooij, K. W., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191791 · Cited by 23

Documento de Consenso de Expertos sobre bloqueadores de los receptores ß-adrenérgicos

Beta, G. D. T. S. B., & de Cardiología, D. L. S. E. (2005) · Revista Española de Cardiología · doi:10.1157/13070510 · Cited by 22

Treatment of Hyperlipidemia from Japanese Evidence

Koba, S., & Sasaki, J. D. (2006) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.13.267 · Cited by 22

Use of A Treatment Algorithm to Achieve NCEP ATP III Goals With Atorvastatin

McKenney, J. M., Davidson, M. H., Saponaro, J., Thompson, P. D., & Bays, H. E. (2005) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000180901.70607.72 · Cited by 22

Interleukin 8 and Susceptibility to Coronary Artery Disease: a Population Genetics Perspective.

Vogiatzi, K., Apostolakis, S. Z., Voudris, V. V., et al. (2008) · Journal of Clinical Immunology · doi:10.1007/s10875-008-9194-3 · Cited by 22

A Health Economic Evaluation of Aspirin in the Primary Prevention of Cardiovascular Disease in Japan

Tsutani, K., Igarashi, A., Fujikawa, K., Evers, T., Kubin, M., Lamotte, M., & Annemans, L. (2007) · Internal Medicine · doi:10.2169/internalmedicine.46.1843 · Cited by 23

The From The Heart study: a global survey of patient understanding of cholesterol management and cardiovascular risk, and physician–patient communication

Hobbs, R. F., Erhardt, L., Rycroft, C. E., & on behalf of the From The heart study investigators (2008) · Current Medical Research and Opinion · doi:10.1185/030079908x280491 · Cited by 22

Update on integrated biomarkers for assessment of long-term risk of cardiovascular complications in initially healthy subjects and patients with manifest atherosclerosis

Köenig, W. (2009) · Annals of Medicine · doi:10.1080/07853890902769675 · Cited by 22

Achieving lipid goals in real life: the Dutch DISCOVERY Study

Bots, A. F. E., Kastelein, J. J. P., & on behalf of the discovery netherlands investigators (2005) · International Journal of Clinical Practice · doi:10.1111/j.1368-5031.2005.00708.x · Cited by 22

Carotid intima-media thickness in low-risk individuals with asymptomatic atherosclerosis: baseline data from the METEOR study

Crouse, J. R., Grobbee, D. E., O’Leary, D. H., Bots, M. L., Evans, G. W., Palmer, M. K., Riley, W. A., Raichlen, J. S., & on behalf of the METEOR study Group (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x178711 · Cited by 22

Secondary Prevention of Acute Coronary Syndrome. Socio-economic and Lifestyle Determinants: A Literature Review

Notara, V., Panagiotakos, D. B., & Pitsavos, C. E. (2014) · Central European Journal of Public Health · doi:10.21101/cejph.a3960 · Cited by 23

Lipids and Stroke: The Opportunity of Lipid-Lowering Treatment

Mora, J. V., & Gil-Núñez, A. (2005) · Cerebrovascular Diseases · doi:10.1159/000089357 · Cited by 22

Valoración del riesgo cardiovascular. ¿Qué tabla utilizar?

Galán, A. M. (2003) · Atención Primaria · doi:10.1016/s0212-6567(03)79337-8 · Cited by 22

The therapeutic potential of CETP inhibitors: a patent review

Wang, X., Li, W., Hao, L., Xie, H., Hao, C., Liu, C., Li, W., Xiong, X., & Zhao, D. (2018) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2018.1439476 · Cited by 22

Kardiovaskuläre Risikoabschätzung in der Hausarztpraxis (DETECT)

Silber, S., Jarre, F., Pittrow, D. B., Klotsche, J., Pieper, L., Zeiher, A. M., Wïttchen, H., & DETECT-Studiengruppe*, F. D. (2008) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-008-1103-2 · Cited by 22

Genetic diversity of RANTES gene promoter and susceptibility to coronary artery disease and restenosis after percutaneous coronary intervention

Vogiatzi, K., Voudris, V. A., Apostolakis, S. Z., et al. (2009) · Thrombosis Research · doi:10.1016/j.thromres.2008.12.043 · Cited by 21

Cost-effectiveness of rosuvastatin in comparison with generic atorvastatin and simvastatin in a Swedish population at high risk of cardiovascular events

Gandhi, S. K., Gandhi, S. K., Fox, K. M., Smolen, Jensen, OLSSON, A. G., & Paulsson (2012) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s26621 · Cited by 21

Apolipoprotein B as a long‐term predictor of mortality in type 1 diabetes mellitus: a 15‐year follow up

Stettler, C., Suter, Y., Allemann, S., Zwahlen, M., Christ, E., & Diem, P. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01690.x · Cited by 21

Relationship of Illness Severity with Health and Life Satisfaction in Patients with Cardiovascular Disease: The Mediating Role of Self-efficacy Beliefs and Illness Perceptions

Steca, P., Greco, A., D’Αddario, M., Monzani, D., Pozzi, R., Villani, A., Rella, V., Giglio, A., Malfatto, G., & Parati, G. (2012) · Journal of Happiness Studies · doi:10.1007/s10902-012-9397-4 · Cited by 21

All-cause Mortality and Mortality of Myocardial Infarction for 989 Legally Castrated Men

von Eyben, F. E., Graugaard, C. L., & Væth, M. (2005) · European Journal of Epidemiology · doi:10.1007/s10654-005-2150-0 · Cited by 21

Aspirin in cardiology - benefits and risks

Björklund, L., Wallander, M.-A. A., Johansson, S., & Lesén, E. (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01908.x · Cited by 21

Patient and Other Factors Influencing the Prescribing of Cardiovascular Prevention Therapy in the General Practice Setting With and Without Nurse Assessment

Mohammed, M. A., El‐Sayed, C., & Marshall, T. P. (2012) · Medical Decision Making · doi:10.1177/0272989x12437246 · Cited by 21

Ethnic differences in total and HDL cholesterol among Turkish, Moroccan and Dutch ethnic groups living in Amsterdam, the Netherlands

Ujčič-Voortman, J. K., Bos, G., Baan, C. A., et al. (2010) · BMC Public Health · doi:10.1186/1471-2458-10-740 · Cited by 21

Is Diabetes Mellitus a Coronary Heart Disease Equivalent? Results of a Meta-Analysis of Prospective Studies

González-Clemente, J. M., Palma, S., Arroyo, J., Vilardell, C., Caixàs, A., Giménez‐Palop, O., & Delgado‐Rodríguez, M. (2007) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(08)60047-x · Cited by 21

Physicians, patients, and public knowledge and perception regarding hypertension and stroke: a review of survey studies

Volpe, M., & Dedhiya, S. D. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x112570 · Cited by 21

Managing cardiovascular risk: reality vs. perception

Erhardt, L. (2005) · European Heart Journal Supplements · doi:10.1093/eurheartj/sui080 · Cited by 21

Out of hospital sudden cardiac death in Italy: a population-based case–control study

Filippi, A., Sessa, E., Mazzaglia, G., Pecchioli, S., Capocchi, R., Caprari, F., Scivales, A., & Cricelli, C. A. (2008) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e3282f2c9d0 · Cited by 21

Effect of acute changes in oxygen tension on flow-mediated dilation. Relation to cardiovascular risk

Fröbert, O., Holmager, P., Jensen, K. M., et al. (2008) · Scandinavian Cardiovascular Journal · doi:10.1080/14017430701466402 · Cited by 21

Reduced Mortality Rates after Intensive Statin Therapy in Managed-Care Patients

Fintel, D. J., Joyce, A. T., Mackell, J. A., et al. (2007) · Value in Health · doi:10.1111/j.1524-4733.2006.00163.x · Cited by 21

Cardiovascular Risk Estimation by Professionally Active Cardiovascular Nurses: Results from the Basel 2005 Nurses Cohort∗

Reimer, W. J. M. S. O., Moons, P., Geest, S. D., Fridlund, B., Heikkilä, J., Jaarsma, T., Lenzen, M. J., Mårtensson, J., Norekvål, T. M., Smith, K. M., et al. (2006) · European Journal of Cardiovascular Nursing · doi:10.1016/j.ejcnurse.2006.06.007 · Cited by 21

Variation of patients’ views on Type 2 diabetes management over time

Vég, A., Rosenqvist, U., & Sarkadi, A. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.02064.x · Cited by 21

Prognostic value of electron-beam computed tomography-derived coronary calcium scores compared with clinical parameters in patients evaluated for coronary artery disease

Schmermund, A., Stang, A., M�hlenkamp, S., Eggebrecht, H., Baumgart, D., Gilbert, V., Gr�nemeyer, D. H. W., Seibel, R., & Erbel, R. M. (2004) · Zeitschrift für Kardiologie · doi:10.1007/s00392-004-0120-2 · Cited by 21

Genetics of high-density lipoproteins

Dastani, Z., Engert, J. C., Genest, J. J., & Marcil, M. (2006) · Current Opinion in Cardiology · doi:10.1097/01.hco.0000231403.94856.cd · Cited by 21

Be physically active: the best buy in promoting heart health

DeBacker, G., & Bacquer, D. D. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.10.014 · Cited by 20

Protocol for CHANGE: a randomized clinical trial assessing lifestyle coaching plus care coordination versus care coordination alone versus treatment as usual to reduce risks of cardiovascular disease in adults with schizophrenia and abdominal obesity

Speyer, H., Nørgaard, H. C. B., Hjorthøj, C., Madsen, T. A., Drivsholm, S., Pisinger, C., Gluud, C., Mors, O., Krogh, J., & Nordentoft, M. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0465-2 · Cited by 20

Hábitos alimentares na prevenção de doenças cardiovasculares e fatores associados em idosos hipertensos

Gadenz, S. D., & Benvegnú, L. A. (2013) · Ciência & Saúde Coletiva · doi:10.1590/s1413-81232013001200009 · Cited by 20

The year in cardiology: cardiovascular prevention

Ray, K. K., Laufs, U., Cosentino, F., Lobo, M. D., & Landmesser, U. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz929 · Cited by 20

The impact of in-hospital cardiac rehabilitation program on medication adherence and clinical outcomes in patients with acute myocardial infarction in the Lazio region of Italy

Soldati, S., Martino, M. D., Rosa, A. C., Fusco, D., Davoli, M., & Mureddu, G. F. (2021) · BMC Cardiovascular Disorders · doi:10.1186/s12872-021-02261-6 · Cited by 23

Comparative effectiveness of different types of exercise in reducing arterial stiffness in children and adolescents: a systematic review and network meta-analysis

Sequí‐Domínguez, I., Mavridis, D., Cavero‐Redondo, I., Saz‐Lara, A., Martínez‐Vizcaíno, V., & de Arenas‐Arroyo, S. N. (2023) · British Journal of Sports Medicine · doi:10.1136/bjsports-2022-106285 · Cited by 20

n−3 PUFAs in cardiovascular disease

Marchioli, R., & Levantesi, G. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.06.042 · Cited by 22

Absence of Increase in Carotid Artery Intima-Media Thickness in Infants of Diabetic Mothers

Atabek, M. E., Çağan, H. H., Eklioğlu, B. S., & Oran, B. (2011) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.v3i3.28 · Cited by 20

Early detection of coronary artery disease by 64-slice multidetector computed tomography in asymptomatic hypertensive high-risk patients

Gaudio, C., Mirabelli, F., Pelliccia, F., Francone, M., Tanzilli, G., Michele, S. D., Leonetti, S., Vincentis, G. D., Carbone, I., Mangieri, E., et al. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.03.091 · Cited by 20

The prevalence of metabolic syndrome and its associated factors in long-term patients in a specialist psychiatric hospital in South Africa

Maaroganye, K., Mohapi, M., Krüger, C., & Rheeder, P. (2013) · African Journal of Psychiatry · doi:10.4314/ajpsy.v16i6.53 · Cited by 20

Cardiovascular Risk Factors and Signs of Subclinical Atherosclerosis in the Heinz Nixdorf Recall Study

Erbel, R., Möhlenkamp, S., Lehmann, N., Schmermund, A., Moebus, S., Stang, A., Dragano, N., Hoffmann, B. H., Grönemeyer, D. H. W., Seibel, R. M. M., et al. (2008) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2008.0001 · Cited by 20

A pilot quality improvement intervention in patients with diabetes and hypertension in primary care settings of Cyprus

Samoutis, G., Soteriades, E. S., Stoffers, J., Philalithis, A. E., Delicha, E., & Lionis, C. D. (2010) · Family Practice · doi:10.1093/fampra/cmq009 · Cited by 20

Arterial stiffness in patients with coronary artery disease: relation with in-stent restenosis following percutaneous coronary intervention

Prskalo, Z., Brizić, I., Markota, D., et al. (2016) · BMC Cardiovascular Disorders · doi:10.1186/s12872-016-0305-4 · Cited by 20

Decline in risk of recurrent cardiovascular events in the period 1996 to 2014 partly explained by better treatment of risk factors and less subclinical atherosclerosis

Berkelmans, G. F. N., van der Graaf, Y., Dorresteijn, J. A. N., de Borst, G. J., Cramer, M. J., Kappelle, L. J., Westerink, J., & Visseren, F. L. J. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.07.026 · Cited by 20

Effect of evolocumab on lipoprotein apheresis requirement and lipid levels: Results of the randomized, controlled, open-label DE LAVAL study

Baum, S. J., Sampietro, T., Datta, D. B. N., Moriarty, P. M., Knüsel, B., Schneider, J., Somaratne, R. M., Kurtz, C. E., & Hohenstein, B. (2019) · Journal of clinical lipidology · doi:10.1016/j.jacl.2019.10.003 · Cited by 19

Impact of active smoking on the immature platelet fraction and its relationship with the extent of coronary artery disease

Nardin, M., Verdoia, M., Negro, F., Rolla, R., Tonon, F., & Luca, G. D. (2019) · European Journal of Clinical Investigation · doi:10.1111/eci.13181 · Cited by 21

Is improvement in depression in patients attending cardiac rehabilitation with new-onset depressive symptoms determined by patient characteristics?

Sever, S., Doherty, P., Golder, S., & Harrison, A. S. (2020) · Open Heart · doi:10.1136/openhrt-2020-001264 · Cited by 18

Misleading Measurements: Modeling the Effects of Blood Pressure Misclassification in a United States Population

Marshall, T. P. (2006) · Medical Decision Making · doi:10.1177/0272989x06295356 · Cited by 20

Regional variation in prescribing for chronic conditions among an elderly population using a pharmacy claims database

Naughton, C., Bennett, K., & Feely, J. (2006) · Irish Journal of Medical Science (1971 -) · doi:10.1007/bf03169170 · Cited by 20

Committee and Task Force Reports: Youth and Families Task Force Report

James, S., Jordan, K., Lasser, J. S., et al. (1997) · PsycEXTRA Dataset · doi:10.1037/e413432005-005

Ethnic Minority Elderly: A Task Force Report of the American Psychiatric Association

Busse, E. W. (1995) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199524310-00013 · Cited by 1

Committee and Task Force Reports: Task Force on Aging

Carlson, H. M., & David, S. (2004) · PsycEXTRA Dataset · doi:10.1037/e373992004-024

Committee and Task Force News: Task Force on Students-at-Risk

Kaslow, F. W., & Olson, D. L. (1991) · PsycEXTRA Dataset · doi:10.1037/e410102005-024 · Cited by 1

Update From the American Psychiatry Association's Task Force on Electroconvulsive Therapy

McDonald, W. M., Prudic, J., McCall, W. V., et al. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2012.12.078 · Cited by 3